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Common symptoms of chronic suppurative lung disease or bronchiectasis in children 
and adolescents are chronic cough with sputum production, retention of excess 
secretions in dilated airways, and a history of recurrent infections. Clinical management 
includes the prescription of airway-clearance techniques (ACTs) to facilitate mucociliary 
clearance, optimize sputum expectoration, relieve symptoms, and improve well-being. 
A wide range of ACTs are available for selection, and these strategies may be applied in 
isolation or in combination. The choice of technique will depend in part on the age of the 
child, their clinical state, and factors which may influence treatment adherence. While the 
evidence base for ACTs in children and adolescent with these conditions is not robust, 
the current available evidence in addition to clinical expertise provides guidance for tech-
nique prescription and clinical effect. An overview of the most commonly applied ACTs, 
including their physiological rationale and discussion of factors influencing prescription in 
children and adolescents is outlined in this review.
Keywords: bronchiectasis, airway-clearance techniques, positive expiratory pressure, mucus production, 
breathing techniques
inTRODUCTiOn
Chronic suppurative lung disease (CSLD) is a clinical syndrome in children of respiratory symptoms 
and signs. Typical symptoms and signs include chronic, productive cough with purulent sputum 
greater than three episodes per year for longer than 4 weeks. This may be accompanied by exertional 
dyspnea and recurrent infections (1). In bronchiectasis, unrelated to cystic fibrosis (CF), this clinical 
presentation is accompanied by radiographic features on high-resolution computed tomography. 
Common causes of CSLD and bronchiectasis include primary ciliary dyskinesia, humoral immuno-
deficiency, and chronic aspiration (1, 2). With both conditions characterized by chronic cough and 
mucus production, airway-clearance techniques (ACTs) are advocated to facilitate the removal of 
retained secretions (1, 2).
Airway-clearance techniques are widely prescribed in bronchiectasis (3–6), generally for the long 
term. While often introduced at the time of diagnosis, airway-clearance strategies may adapt and 
change, according to the presence and frequency of acute exacerbations. No single type of technique 
is superior to another (7) and physiotherapy prescription of ACTs in children with bronchiectasis is 
variable (5). While technique selection and prescription is individualized, the chosen ACTs should 
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impose minimal risk of adverse events or aggravation of other 
symptoms or comorbidities. There are multiple ACTs available, 
ranging from traditional techniques and those which promote 
greater independence.
For children and adolescents with CSLD or bronchiectasis, the 
principles of ACTs follow what has been described for the adult 
population and for children with CF. This is partially due to the 
challenges of ACT research, with the need for long-term stud-
ies with large patient numbers. Given the paucity of research in 
the bronchiectasis pediatric and adolescent population, clinical 
practice has evolved from existing evidence and clinical exper-
tise. However, specific factors which may influence a technique’s 
effectiveness should be considered when prescribing ACTs for 
this age group.
Parents of children with bronchiectasis report higher levels of 
depression (8, 9). Adolescents with bronchiectasis have a higher 
rate of depression (10). The psychological state of parent and child 
with CSLD or bronchiectasis may influence adherence to ACT 
(11) and non-adherence is the primary cause of treatment failure 
in chronic pediatric lung conditions (11). In addition to child or 
parental depression, other contributing factors are complexity 
and demands of a specific treatment routine, lack of support, the 
need to preserve both family relationships, and a child’s sense 
of normality (12). Together with an individual’s clinical state, a 
physiotherapist or respiratory therapist needs to consider these 
factors when working with a child or adolescent and their family.
This review will provide suggestions for age-appropriate ACTs 
for children and adolescents with bronchiectasis or CSLD and 
will outline the most common clinical techniques, the available 
evidence, and practical considerations for prescription.
AGe COnSiDeRATiOnS
The choice of ACT should be tailored toward the child’s age. Their 
level of cooperation, maturity, and psychological adjustment to 
their condition is all important factors, as are the interactive 
skills of the physiotherapist and parents (13). Table 1 outlines a 
guide for age-appropriate ACTs in children and adolescents with 
bronchiectasis or CSLD. As a child matures, the type of ACT pre-
scribed is likely to change, with greater autonomy in undertaking 
self-administered techniques.
TYPeS OF TeCHniQUeS
Gravity-Assisted Drainage (GAD) and 
Manual Techniques
Gravity-assisted drainage involves placing the patient in specific 
(including semi-recumbent) positions which enables gravity to 
drain excess secretions from bronchopulmonary segments (14, 
15). Infants and toddlers may be positioned on a caregivers’ lap, 
while older children and adolescents use a couch/bed. While 
traditional positioning involves a head-down tilt in selected 
positions, gastro-esophageal reflux (GOR) in infants and children 
with CF (16–19) has led to adopting a modified GAD approach 
(ModGAD), which eliminates a head-down tip for those suspected 
of or demonstrating GOR (5, 18). Despite no evidence that GAD 
aggravates GOR in children or adolescents with bronchiectasis, 
the presence of this comorbidity (20, 21) implies the potential 
need for applying ModGAD as required. In addition, ModGAD 
has demonstrated equivalent effectiveness as traditional GAD 
and is preferred by patients with bronchiectasis (22).
This technique is often combined with manual techniques, 
such as chest percussion or vibrations, with the technique appli-
cation adjusted for the child’s age (23, 24). The application of 
force to the chest wall creates changes in the intrapleural pressure, 
which are transmitted through the thoracic cage and assist in 
dislodging secretions. Chest wall vibrations apply fine oscillatory 
movements with chest wall compression, initiated at the end of 
inspiration and applied during expiration.
Despite the lack of focused research of these techniques 
in children and adolescents with bronchiectasis, GAD or 
more commonly ModGAD improves secretion clearance and, 
combined with manual techniques, is equally effective as other 
ACTs (25–27). Some studies of individuals with bronchiectasis 
demonstrate greater sputum expectoration with GAD and 
manual techniques compared to oscillating positive expiratory 
pressure (PEP) therapy or the active cycle of breathing technique 
(ACBT) (22, 28). The application of ModGAD with percussion 
and/or vibrations is most commonly applied in infants and young 
children or reserved for older individuals who cannot manage 
their own treatment.
Active Cycle of Breathing Technique
The ACBT consists of thoracic expansion exercises and the forced 
expiratory technique (FET) (29, 30). The technique is applied 
in an upright sitting, ModGAD, or other recumbent positions. 
Thoracic expansion exercises are deep breathing exercises, 
with an emphasis on slow, controlled inspiration. Inspiration 
is believed to facilitate collateral channel ventilation to reach 
behind secretions. Breathing control is tidal volume breathing 
to relieve breathlessness, which may be generated during more 
active components of ACBT (31). The FET is a key component 
of ACBT. It is a combination of one to two forced expirations 
(huffs) and breathing control. The huff comprises of controlled 
expiration through an open glottis to near low volumes. During 
a forced expiration, the equal pressure point moves peripherally 
into the smaller airways. Secretions are mobilized by commenc-
ing huffing at low, mid, and high lung volumes. FET maneuvers 
are the most effective part of chest physiotherapy (32), with this 
technique frequently applied with other ACTs (33).
To encourage glottis opening, a peak-flow mouthpiece or 
similar piece of tubing may be used, providing audible feedback 
to children learning the technique (Figure  1A). Commencing 
huffing games in toddlers is a useful initial strategy to encourage 
the correct technique.
Only studies of adults with bronchiectasis undertaking ACBT 
(in recumbent positions) have been conducted, and when com-
pared to other techniques, similar improvements in quality of life 
and lung function have been consistently noted (28, 34, 35).
Positive expiratory Pressure (Therapy)
Positive expiratory pressure therapy uses a one-way valve that 
allows unrestricted inspiration and a resistance to expiration. 
TABLe 1 | A guide to age-appropriate airway-clearance techniques for children and adolescents with bronchiectasis or chronic suppurative lung 
disease.
Technique Age range Advantages Disadvantages
Modified GAD or GAD All age ranges Suitable for infants and small children who are 
not yet old enough to cooperate with more active 
techniques
Discomfort, time consuming, symptoms of gastro-
esophageal reflux or breathlessness, specific 
contraindications or precautions
Option for those unable to use or too fatigued to 
use independent techniques
Percussion and vibrations All age ranges Suitable for infants and small children who are 
not yet old enough to cooperate with more active 
techniques
Passive, require assistant, discomfort, inconvenient, 
socially limiting
Option for those unable to use or too fatigued to 
use independent techniques
Assisted autogenic drainage Infants Minimal equipment required Requires assistance, difficult technique to master 
and for carers to learn
Bouncing on a fitball Infant to toddler Enjoyable for child Equipment required
Blowing games Toddler to child Enjoyable for child
Huffing Toddler to adolescent Enjoyable for child
ACBT (includes huffing) Toddler to adolescent Independent, flexible, requires no equipment, can 
be combined with other techniques
Bottle PEP Toddler to adolescent Independent technique, enjoyable for child, can be 
a bridge to other forms of PEP therapy, minimal 
cost
Need to follow instructions to avoid swallowing water
Autogenic drainage Toddler to adolescent Independent technique, nil equipment required Effect and feedback required to master the 
technique including sensitivity to auditory and 
vibratory cues of secretions
PEP mask Toddler to adolescent Independent technique, can be combined with 
other ACTs, beneficial for those with unstable or 
compliant airways
Infant PEP requires assistance. Requires individual 
awareness of breath size
For younger children who are afraid of a mask, this 
may not be the technique of choice
Cost
Mouthpiece PEP Toddler to adolescent Independent technique, can be combined with 
other ACTs, beneficial for those with unstable or 
compliant airways
No clear evidence on use of Mouthpiece PEP—
either with or without nose clip
Cost
Can be used in conjunction with hypertonic saline 
nebulizer (see below)
Easy for younger children to use
PariPEP™ with nebulizer Toddler to adolescent Independent technique, can be combined with 
other ACTs, beneficial for those with unstable or 
compliant airways
Cost
Flutter® Child to adolescent Independent technique Effective use dependent on angle, therefore, may be 
more suited to an older child (8 years). Cost
Acapella® Toddler to adolescent Independent technique, can be combined with 
other ACTs, beneficial for those with unstable or 
compliant airways
Cost
Not position dependent
Aerobika™ Toddler to adolescent Independent technique, can be used in 
conjunction with nebulizer
Cost
Physical exercise Toddler to adolescent Enjoyable for child
HFCWO Toddler to adolescent Independent technique Heavy device, not easily portable
Cost
GAD, gravity-assisted drainage; ACBT, active cycle of breathing technique; PEP, positive expiratory pressure; ACT, airway-clearance technique; HFCWO, high-frequency chest wall 
oscillations.
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The theoretical rationale for PEP is that in the presence of small 
airway obstruction, PEP therapy promotes airflow past the 
obstruction or through the collateral channels. This allows an 
increased volume of air to accumulate behind secretions while 
the pressure gradient across the sputum plug forces secretions 
toward the larger airways (36, 37). During expiration, the positive 
FiGURe 1 | examples of airway-clearance techniques: (A) huffing, (B) infant positive expiratory pressure (PeP) mask, (C) oscillating PeP (OscPeP) 
with Flutter®, (D) OscPeP with Acapella®, (e) bottle PeP, (F) assisted autogenic drainage. Permission to publish images has been granted by individuals or 
on behalf of the individuals.
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pressure is thought to increase functional residual capacity, 
preventing premature airway collapse (38). Breathing cycles are 
coupled with FET as required.
A commonly applied PEP therapy system consists of a close-
fitting mask and a one-way valve to which expiratory resistors are 
attached. Alternatively, a mouthpiece with holes of varying diam-
eters (PariPEP™) to apply expiratory resistance or a TheraPEP® 
is used. A manometer determines the correct pressure generated 
during initial therapy instruction. For low pressure PEP therapy, 
the resistor giving a pressure level of 10–25 cmH2O during the 
middle of expiration is an ideal selection (39, 40). While PEP 
therapy may be used in young children and adolescents of all ages 
(from infancy to older age), there is a slight variation with infant 
PEP, with an appropriately sized face mask held over the infant’s 
nose and mouth (Figure 1B). Generation of specific pressures is 
not a goal of infant PEP therapy due to poorly developed collat-
eral ventilation. It is often combined with a physical activity, such 
as sitting and bouncing on a fit ball, with the additional activity 
modulating lung volumes. For younger children afraid of a mask, 
PEP mask is not the technique of choice.
Most studies of PEP therapy in children and adolescents have 
been conducted in CF. Short-term PEP therapy is associated with 
similar sputum expectoration, lung function, and well-being as 
other ACTs, although PEP is a preferred technique (41). One long-
term study of PEP for 12 months in children with CF concluded 
that PEP was superior to GAD with manual techniques (42). In 
infants with CF, twice daily infant PEP was safe and improved gas 
exchange compared to ModGAD over a 12-month period (43).
Oscillating PeP (OscPeP) Therapy
Oscillating PEP therapy offers the combination of PEP with 
high-frequency oscillations which elicit shear forces within 
the airways during exhalation to facilitate secretion clearance. 
The oscillations are believed to induce vibrations within the 
airway wall to displace secretions and the repeated accelera-
tions of expiratory airflow favor movement of secretions from 
the peripheral to the central airways (44). There are several 
devices which provide OscPEP therapy, with the Flutter® and 
Acapella® among the most common. Other devices which 
provide similar effects are the Aerobika™, the Quake, and the 
RC-Cornet®.
The Flutter® is a small pipe-shaped hand-held device with a 
mouthpiece, a perforated cover which encases a stainless steel ball 
resting in a circular cone. Inhalation occurs through the nose or 
around the mouthpiece. During expiration, at a slightly faster rate 
than normal, the high-density ball rolls up and down the cone, 
creating interruptions in expiratory flow and generating a PEP 
within the range of 18–35 cmH2O (45). An oscillatory vibration 
of the air is generated which shear secretions from the airways 
and reduces the viscoelasticity of the secretions (44). Cycles of 
inspiration and expiration are repeated, followed by FET and 
coughing as required. The frequency of oscillations is determined 
by the angle at which the device is held (46). It can be difficult 
for children to maintain the angle position for an extended 
length of time and consistently achieve maximal effect. Optimal 
technique may be more evident with older children (8 years and 
up) (Figure 1C).
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Acapella®
The Acapella® uses a counterweighted plug and magnet to 
create airflow oscillations (47). The frequency/resistance dial 
allows adjustments to the expiratory pressure and the oscilla-
tion frequency, with the device used with either a mouthpiece 
or mask. Inspiration can occur through the nose or mouth, with 
an inspiratory pause and a more active exhalation, followed by 
FET. The Acapella® is flexible in the positions in which it can be 
used (upright and recumbent). In children, the resistance level 
is set low initially (number 1 or 2) and then increased slowly as 
necessary. When instructing a toddler or child, 5 or 10 breaths 
may be an initial attempt. Once the child masters the blowing 
technique, a more formal number of breaths and frequency is 
provided (Figure 1D).
Other OscPeP Devices
The RC-Cornet® consists of a mouthpiece, curved tube, a valve 
hose, and a sound damper, with expiration through the tube 
creating an increasing pressure within the hose until it opens, 
allowing air to flow through the device and creating a PEP 
and vibrations within the airways. Similar to an Acapella, the 
Aerobika™ includes a mouthpiece and one-way valve. Nebulizer 
therapy can also be incorporated into the circuit as well to deliver 
mucolytic therapy.
The majority of research of OscPEP in bronchiectasis has 
focused on the Flutter®, Acapella®, and RC-Cornet® in adults. 
When applied in the short term (single treatment session) or long 
term (4 weeks or 3 months), OscPEP improved sputum expecto-
ration and HRQOL compared to no treatment (25, 48). However, 
when compared to other ACTs, the effects upon sputum expecto-
ration, spirometry, gas exchange, and symptoms were equivalent 
(28, 34, 35, 49), although its independence is preferred by patients 
(28). Considering the degree of monitoring required of the child’s 
technique to minimize airway closure may be important factors 
in selecting OscPEP therapy for some children.
Bottle PeP
Bottle or Bubble PEP is an alternative method to administer 
low pressure OscPEP therapy, particularly for children less than 
4 years, who no longer tolerate infant PEP but are not yet able to 
progress to other forms of ACT. The resistance in this set up is a 
water column, with the expiratory pressure remaining constant 
once the tubing diameter is >5 mm (50). It consists of smooth 
bore rubber tubing and a plastic bottle (1–2 L) that is approxi-
mately ½ filled with water. The child inhales through his/her nose 
or around the tube in his/her mouth and expires through the tube 
into the column of water. Blowing through the tubing creates 
bubbles in the bottle. The height of the water (approximately 
10 cm above the bottom of the tube) provides the PEP while the 
bubbling produces oscillations in the airways. For children, the 
addition of liquid detergent and a small quantity of food coloring 
adds to the novelty of the treatment (Figure 1E). For children with 
bronchiectasis and a comorbidity (i.e., cerebral palsy), a facemask 
Bottle PEP can be set up with a one-way valve. Initial use with 
toddlers/children may allow blowing as many times as they wish 
to see that they are creating bubbles and maintain engagement. 
Once the blowing is mastered, a more formal number of breaths 
and sets are instructed. Despite use in clinical practice (6, 51–54), 
the evidence for Bottle PEP is scarce and consideration regarding 
approval as a medical device may be necessary (55).
Autogenic Drainage (AD)
Autogenic drainage is a technique which maximizes airflow 
to promote ventilation and secretion clearance. It employs the 
principles of breathing at different lung volumes to loosen and 
mobilize secretions (56). The aim is to achieve the highest pos-
sible expiratory airflow while avoiding dynamic airway collapse 
(57). The speed of the expiratory flow reduces mucus adhesion, 
shears secretions from bronchial walls, and transports them from 
the peripheral to proximal airways (58). AD consists of three 
phases and the duration of each phase will depend on the efficacy 
of airflow to mobilize secretions.
In those with bronchiectasis, a single session of AD cleared 
more secretions compared to no treatment (59). Long-term stud-
ies in children with CF comparing AD to OscPEP, PEP mask, 
or ACBT have demonstrated clinical equivalence between ACTs 
(33). In adolescents, although clinical benefit was similar, a prefer-
ence for AD over GAD and manual techniques was evident over 
the 2-year study (60). This highlights the importance of patient 
preference and its impact on adherence (61). While AD is flex-
ible, it is a complex and technically difficult treatment strategy. 
Requiring patience and cooperation, it takes time for child or 
adolescent to learn and utilize feedback to adequately perform the 
technique. For this reason, it is not suitable for young children.
An alternative adaptation is assisted AD, which may be 
applied for infants and young children. Assisted AD is achieved 
by applying gentle manual pressure to the child’s chest wall by the 
physiotherapist/parent/caregivers’ hands to increase expiratory 
flow and achieve different lung volume breathing (55). The infant 
or child is supported on a physiotherapist/caregiver’s lap, who is 
often sitting on a fit ball. Assisted AD is performed in a gentle and 
progressive way, using the patient’s breathing pattern; the option 
of bouncing on a fit ball encourages relaxation of the child and 
enhances expiratory air velocity (Figure 1F). As an infant or child 
needs to remain still for a period of time for the technique to be 
effective, it can be difficult to use for some children.
High-Frequency Chest wall Oscillation 
(HFCwO) and intrapulmonary Percussion
High-frequency chest wall oscillation applies external chest wall 
oscillations via an inflatable vest worn around the torso (62). 
Increasing the air-liquid shear forces during expiration is believed 
to result in secretion mobilization. Although only applied in 
adults with bronchiectasis, the HFCWO improved pulmonary 
function and quality of life and reduced dyspnea compared to 
GAD with breathing techniques (63). Although unstudied in 
pediatric populations with bronchiectasis, it is an option if the 
cost is not prohibitive and has been applied in children with 
neurological conditions and bronchiectasis, with a reduced 
incidence of pneumonia over 12  months (64). Other options 
include intrapulmonary percussive ventilation, which provides 
high-frequency oscillatory ventilation to produce endotracheal 
percussion. Models of acoustic percussion (The Frequencer™ 
and Vibralung®) induce vibrations in the chest wall and are an 
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alternative option to therapist-delivered manual techniques. 
However, there is minimal evidence of their clinical effects in the 
bronchiectasis or CSLD pediatric populations.
exercise
Physical exercise, particularly endurance activity, is highly rec-
ommended for all ages in the management of bronchiectasis and 
CSLD (65), with endurance and muscle and bone strengthening 
activities included. Activity selection is age-dependent and incor-
porated into school sporting or external activities where possible. 
Ideally, toddlers and young children have fun, physical activities 
interspersed with other ACTs (66). For older children, cycles of 
exercise of a moderate intensity are mixed with ACBT, AD, PEP 
therapy, or FET. Not only does it promote general health and well-
being but exercise is a more effective bronchodilator compared to 
beta-agonists in primary ciliary dyskinesia (65).
Adjuncts to ACTs
Other options which may facilitate ACTs include mucoactive 
agents, delivered by nebulized inhalation therapy. Hypertonic 
saline is classed as an expectorant and may be inhaled before 
or during an ACT (2). It increases airway surface hydration to 
reduce secretion viscosity (67). Although beneficial in adults with 
bronchiectasis, improving lung function (68), the superiority of 
hypertonic saline over isotonic saline is unclear (69). While not 
recommended for routine use (1), a therapeutic trial in children 
experiencing frequent acute exacerbations can be considered.
COnCLUSiOn
A key component of managing CSLD or bronchiectasis in chil-
dren and adolescents involves ACTs and exercise and although 
the evidence base is lacking, clinical practice reflects their regular 
prescription and use. Technique choice will vary according to 
age and specific factors influencing patient adherence. Working 
closely with the child or adolescent and their family in a therapeu-
tic alliance and providing ongoing education, engagement, and 
encouragement to assist with adherence to therapy is critical in 
maximizing the effectiveness of airway-clearance therapy in these 
populations.
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